Cephradine
Spezifikationen
38821-53-3CAS-Nummer
254-137-8EG-Nummer
(6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acidIUPAC-Name
C16H19N3O4SChemische Formel
349.4 g/molMolekulargewicht
cephradine; Cefradine; 38821-53-3; Cephradin; Anspor; Sefril; Velosef; Cefradina; Eskacef; Cefradinum; SQ 11436; Cephradine anhydrous; DTXSID4022785; SQ-11436; (6R,7R)-7-((R)-2-Amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; 9YA6SX5S4D; 7-(D-2-Amino-2-(1,4-cyclohexadienyl)acetamide)desacetoxycephalosporanicacid; CHEBI:3547; (6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cephradine hydrate; CEFRADINE HYDRATE; SK&F D-39304; NSC-756672; SQ-22022; DTXCID002785; (6R,7R)-7-[(2R)-2-amino-2-(cyclohexa-1,4-dien-1-yl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-(D-2-Amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)-oct-2-ene-2-caboxylic acid; SK&F-D-39304; (6R,7R)-7-{[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino-1,4-cyclohexadien-1-ylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-; (6R,7R)-7-(((2R)-2-AMINO-2-CYCLOHEXA-1,4-DIEN-1-YLACETYL)AMINO)-3-METHYL-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID; Ecosporina; (6R,7R)-7-((2R)-2-amino-2-(cyclohexa-1,4-dien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; Dihydrate, Cephradine; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(2-amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3-methyl-8-oxo-, hydrate, D-; RefChem:575139; VELOSEF'125; VELOSEF'250; VELOSEF'500; F1BC02I72W; J01DA31; Non-Stoichiometric Hydrate Cephradine; Cephradine, Non Stoichiometric Hydrate; SQ11436; 254-137-8; Cefradin; Cefradine [INN]; MFCD00865048; (6R,7R)-7-((R)-2-Amino-2-(cyclohexa-1,4-dien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2R)-amino-1,4-cyclohexadien-1-ylacetyl]amino]-3-methyl-8-oxo-,(6R,7R)-; NCGC00183036-01; Megacef; Cefradinum [INN-Latin]; Cephradine [USAN:BAN]; Cefradina [INN-Spanish]; (7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cekodin; Velocef; Megace f; SKF D 39304; CED; Cephradine (USP); Velosef (TN); VELOSEF '125'; VELOSEF '250'; VELOSEF '500'; Anspor (TN); CAS-38821-53-3; HSDB 3216; Cefradine (JAN/INN); EINECS 254-137-8; UNII-9YA6SX5S4D; BRN 6075388; Infexin; Cefrag; Cefradine CRS; SK-D-39304; Cephradine (Standard); CEFRADINE [JAN]; CEPHRADINE [MI]; CEPHRADINE [HSDB]; CEFRADINE [MART.]; Epitope ID:116210; CEFRADINE [WHO-DD]; SCHEMBL3244; CHEMBL1604; DivK1c_000739; GTPL4830; CEFRADINE [EP MONOGRAPH]; HMS502E21; HY-B1156R; KBio1_000739; NINDS_000739; SQ 22022 [DIHYDRATE]; ADA97570; HY-B1156; MSK12003; Tox21_113488; BDBM50370585; EBC-14619; s4671; Cefradine for peak identification CRS; AKOS015961130; Tox21_113488_1; AA44691; AC-1409; CCG-208520; CS-4608; DB01333; NSC 756672; IDI1_000739; NCGC00183036-02; NCGC00263658-01; (6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-yl-acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-[(2R)-2-(cyclohexa-1,4-dienyl)-2-phenylacetamido]-3-methyl-3,4-didehydrocepham-4-carboxylic acid; AS-75158; C2988; C06897; C74975; D00264; EN300-6479201; Q2734674; BRD-K13797099-001-01-1; Z2235811518; Cefradine, European Pharmacopoeia (EP) Reference Standard; Cefradine for peak identification, European Pharmacopoeia (EP) Reference Standard; (6R,7R)-7-((R)-2-Amino-2-(cyclohexa-1,4-dien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid; (6R,7R)-7-[[(2R)-2-amino-2-(1,4-cyclohexadien-1-yl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid; (6R,7R)-7-{[(2R)-2-Amino-2-(cyclohexa-1,4-dien-1-yl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-((AMINO-1,4-CYCLOHEXADIEN-1-YLACETYL)AMINO)-3-METHYL-8-OXO-, (6R-(6.ALPHA.,7.BETA.(R*)))-; Cefradine Dihydrate; Cephradine dihydrateSynonyme
Produkte, die Cephradine enthalten
세프칼캡슐(세프라딘수화물)다산세프라딘캡슐250밀리그램(세프라딘)(수출용)세파라딘캡슐500밀리그램(세프라딘수화물)다산세프라딘캡슐(수출용)비씨세프라딘주1그램(수출용)일양세프라딘주1그램(세프라딘수화물)(수출용)한프라딘캡슐(세프라딘)(수출용)세라딘캡슐(세프라딘수화물)화일세프라딘주1g (세프라딘)(수출용)(수출명 : Hwadin Inj.)인터메딕세프라딘주1g(수출용)(수출명:BIOSCLORInj.)뉴프라딘캡슐(세프라딘수화물)바이넥스세프라딘주
Seite 1 von 13
Unternehmen, die Cephradine verkaufen
한미
한미약품(주)Republic of Korea(주
(주)유한양행Republic of Korea신풍
신풍제약(주)Republic of Korea일양
일양약품(주)Republic of Korea(주
(주)넥스팜코리아Republic of Korea국제
국제약품(주)Republic of Korea한올
한올바이오파마(주)Republic of Korea오스
오스틴제약(주)Republic of Korea(주
(주)비씨월드제약Republic of Korea한국
한국넬슨제약(주)Republic of KoreaSeite 1 von 9